Genome wide analysis of pathogenic SH2 domain mutations

Ilkka Lappalainen1, Janita Thusberg, Bairong Shen

  • 1Department of Biological and Environmental Sciences, Division of Biochemistry, FI-00014 University of Helsinki, Finland.

Proteins
|February 9, 2008
PubMed

Insights

This study analyzes human disease mutations in Src homology 2 (SH2) domains. Bioinformatics reveals most mutations impact phosphotyrosine binding, explaining SH2 domain-related diseases.

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Src homology 2 (SH2) domains are crucial in cellular signaling.
  • Mutations in SH2 domains are linked to various human diseases, including immunodeficiencies, cancer, and metabolic disorders.

Purpose of the Study:

  • To perform a genome-wide analysis of mutations in human SH2 domains associated with disease.
  • To elucidate the structural and functional basis of SH2 domain-related pathologies using bioinformatics.

Main Methods:

  • Genome-wide analysis of known pathogenic mutations in human SH2 domains.
  • Bioinformatic investigation of protein properties including sequence conservation, structural stability, and ligand binding interactions.

Main Results:

  • Identified disease-causing mutations in SH2 domains of key signaling proteins like BTK, STAT1, and PTPN11.
  • Found that the majority of mutations occur at sites critical for phosphotyrosine ligand binding and specificity.
  • Established the structural underpinnings of SH2 domain-associated diseases.

Conclusions:

  • SH2 domain mutations are a significant cause of diverse human diseases.
  • Bioinformatic analysis provides crucial insights into the molecular mechanisms of these diseases.
  • Understanding these mutations aids in diagnosing and potentially treating SH2 domain-related disorders.